Despite recent ushers in the attention this entity has received, and resources spent for the same, we still seem to be moving in circles rather than moving forward in our quest to better understanding the disease entity, with many of our views still based on supposition rather than on facts, as had been advocated by Corsellis four decades earlier.

However, tau imaging andÂ relevant CSF biomarkers have shown promise in becoming surrogate markers for the definitive diagnosis of patients with CTE.